Pharmaceutical compositions

Abstract

This article provides a pharmaceutical composition comprising ethyl 1-(4-(4-((3-(3,6-difluoropyridin-2-yl)-1-((1r,4r)-4-ethoxycyclohexyl)-1H-pyrazol-4-yl)aminomethoxy)thiazolyl)-1H-pyrazol-1-yl)phosphate or a pharmaceutically acceptable salt thereof as an active agent, one or more in-particle excipients, and one or more out-of-particle excipients. Provided herein is a pharmaceutical composition comprising 1-(4-(4-((3-(3,6-difluoropyridin-2-yl)-1-((1r,4r)-4-ethoxycyclohexyl)-1H-pyrazol-4-yl)carbamoyl)thiazol-2-yl)-1H-pyrazol-1-yl)ethyl phosphate or a pharmaceutically acceptable salt thereof as an active agent, one or more intragranular excipients and one or more extragranular excipients.

Images